GnRH (Triptorelin)
$32.99$49.99
- Concentration
- 100 mcg per vial
Free & Fast
Shipping
Earn
Rewards
Excellent
Service
$32.99$49.99
Free & Fast
Shipping
Earn
Rewards
Excellent
Service
Molecular Formula | C70H87ClN16O13 |
Molecular Weight | 1396.0 |
Monoisotopic Mass | 1394.6327046 |
Polar Area | 444 |
Complexity | 2910 |
XLogP | 2.9 |
Heavy Atom Count | 100 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 33 |
Physical Appearance | Fine White Lyophilized Powder |
Stability | Lyophilized protein is to be stored at -20°C. It is recommended to aliquot the reconstituted (dissolved) protein into several discrete vials in order to avoid repeated freezing and thawing. Reconstituted protein can be stored at 4°C |
PubChem LCSS | GnRH (Triptorelin) Laboratory Chemical Safety Summary |
Property | Property Value |
---|---|
CID | 25078174 |
CAS | 74611-71-5 |
InChI | InChI=1S/C70H87ClN16O13/c1-39(2)30-59(67(98)79-51(16-9-27-75-70(73)74)69(100)87-29-11-17-57(87)65(96)78-37-60(72)91)85(4)68(99)55(34-44-36-77-50-15-8-6-13-48(44)50)83-62(93)52(32-42-21-25-46(90)26-22-42)80-64(95)56(38-88)84-63(94)54(33-43-35-76-49-14-7-5-12-47(43)49)81-61(92)53(31-41-19-23-45(71)24-20-41)82-66(97)58-18-10-28-86(58)40(3)89/h5-8, 10, 12-15, 18-26, 35-36, 39, 51-59, 76-77, 88, 90H, 9, 11, 16-17, 27-34, 37-38H2, 1-4H3, (H2, 72, 91)(H, 78, 96)(H, 79, 98)(H, 80, 95)(H, 81, 92)(H, 82, 97)(H, 83, 93)(H, 84, 94)(H4, 73, 74, 75)/t51-, 52-, 53+, 54+, 55+, 56-, 57-, 58-, 59-/m0/s1 |
InChIKey | IAIQAABWXYYEFZ-FNLUPMSMSA-N |
Isomeric SMILES | CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)N(C)C(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@@H](CC7=CC=C(C=C7)Cl)NC(=O)[C@@H]8C=CCN8C(=O)C |
Canonical SMILES | CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CC=C(C=C7)Cl)NC(=O)C8C=CCN8C(=O)C |
IUPAC Name | (2S)-1-acetyl-N-[(2R)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-methylamino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-chlorophenyl)-1-oxopropan-2-yl]-2, 5-dihydropyrrole-2-carboxamide |
Generated by Extreme Peptide with Open Babel, version 2.3.1, http://openbabel.org (accessed May 20, 2024)
Gonadotropin releasing hormone (GnRH) is a synthetic, 10 amino acid sequence, which is structurally identical to the naturally occurring anterior pituitary hormone stimulating hypothalamic decapeptide bearing the same name1. Pulses of GnRH from the hypothalamus are responsible for the synthesis and release of gonadotropins like luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are hormones intimately related to mammalian sexual preparation and response2.
In mammalian males, pulses of GnRH initiate the process of testosterone production and spermatogenesis (sperm production)3. The introduction of endogenous GnRH to animal test subjects has been shown to raise males’ testosterone capacity beyond natural levels, which has demonstrated effects of promoting bursts of intense energy and aggressive behaviour4.
GnRH analogues have developed in order exercise further control over the release of GnRH, and in following, LH and FSH. A GnRH agonist was synthesized and was meant to be active in promoting the release of GnRH, though this peptide was found only to cause an initial ‘flare’ of GnRH release, followed by downregulation of native GnRH production in animal tests5. Direct administration of synthetic GnRH, assuming reasonable temporal spacing between treatments, has been shown to induce marked increases in LH, FSH, and testosterone levels during tests with young and old male rats6.
Certain GnRH agonists, like Triptorelin, have been found successful in suppressing LH and FSH production while simultaneous promoting the production of testosterone. During in vivo circulation, this GnRH agonist puts forward a constant stimulatory effect on the pituitary gland.
Gonadotropin Releasing Hormone; Gonadorelin; GnRH; GnRH1; GnRH-1
All literature, information, and data, provided on this website are for informational and educational purposes only.
Accurate research is our priority.
Get 25% off your first order and all the latest information on events, sales, & offers.
We care about keeping your data private. Read our Privacy Policy.